These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1182334

  • 21. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T, Piette M, Kinget R, Delattre L.
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Compounding facility for dermatologic topical medications: a prototype for rural areas of developing countries.
    Maddin S, Ryan T, Kopf AW, Grossman H, Strauss J.
    Int J Dermatol; 1996 Jan; 35(1):63-4. PubMed ID: 8838934
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Proper use of biological indicators in sterilization.
    Brewer JH, Phillips GB.
    Bull Parenter Drug Assoc; 1968 Jan; 22(4):157-69. PubMed ID: 4914499
    [No Abstract] [Full Text] [Related]

  • 29. Smith Kline & French Laboratories, Philadelphia, Pa. Sterile Operations facility.
    Blackmer RA.
    J Parenter Sci Technol; 1984 Jan; 38(5):183-9. PubMed ID: 6512656
    [No Abstract] [Full Text] [Related]

  • 30. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR, Robinson JE.
    J Parenter Sci Technol; 1991 Jan; 45(6):279-85. PubMed ID: 1802984
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A modern research laboratory for sterile preparations.
    Anschel J, Nagy IE.
    Bull Parenter Drug Assoc; 1974 Jan; 28(3):136-45. PubMed ID: 4845937
    [No Abstract] [Full Text] [Related]

  • 33. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract] [Full Text] [Related]

  • 34. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G, Prats S, Bregni C.
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [Abstract] [Full Text] [Related]

  • 35. The advisory role of FDA district offices in the planning of a new parenteral facility.
    Tetzlaff RF.
    J Parenter Sci Technol; 1984 Nov; 38(3):94-7. PubMed ID: 6747781
    [No Abstract] [Full Text] [Related]

  • 36. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP, Hall KW.
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Large scale manufacture of parenterals.
    Hempel HE.
    Bull Parenter Drug Assoc; 1976 Dec; 30(2):88-95. PubMed ID: 949565
    [No Abstract] [Full Text] [Related]

  • 39. Microbiological control for sterile pharmaceutical products.
    Hall NC.
    Bull Parenter Drug Assoc; 1968 Dec; 22(4):187-92. PubMed ID: 4914500
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.